Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:

Daiichi Sankyo Newsletter

Glioma Clinical And Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, And Pipeline Analysis Cellabmed, Oblato, Biomed Valley Discoveries, Pharmabc 11 Jul 2025 03:22 GMT
… -Mab Biopharma, Chimerix, Medicenna Therapeutics, Daiichi Sankyo, Eli Lilly and Company, Candel …
Pexidartinib Elicits Sustained Benefit in Tenosynovial Giant Cell Tumors 10 Jul 2025 23:44 GMT
… of US Medical Affairs at Daiichi Sankyo, the developer of pexidartinib, concluded … phase 3 trial. News release. Daiichi-Sankyo. July 9, 2025. Accessed July …
Patritumab Deruxtecan Shows CNS Efficacy in Metastatic Breast Cancer With Brain Metastases 10 Jul 2025 20:55 GMT
… Bristol-Myers Squibb, CMC Contrast, Daiichi Sankyo, Gan & Lee, Gerson Lehrman … Bristol-Myers Squibb, CMC Contrast, Daiichi Sankyo/Astra Zeneca, Gan … (Inst), Bristol-Myers Squibb (Inst), Daiichi Sankyo (Inst), GlaxoSmithKline (Inst), Merck Sharp …
Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight 11 Jul 2025 00:14 GMT
… Lilly and Company, Novartis AG, DAIICHI SANKYO COMPANY, LIMITED, AbbVie Inc., Lundbeck …
Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight 11 Jul 2025 00:14 GMT
… , Roche, Shanghai Henlius Biotech, AbbVie, Daiichi Sankyo, Nuvation Bio, PDC*line Pharma …
Creative deal structures help life sciences innovators ride out the macro storm 10 Jul 2025 18:15 GMT
… & Co’s partnership with Daiichi Sankyo in 2023 exemplified a multi …
FDA Publishes Cache of Complete Response Letters in Bid for ‘Radical Transparency’ 10 Jul 2025 16:54 GMT
… a chewable gum version of Daiichi Sankyo’s cholesterol medication Welchol from …
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor 09 Jul 2025 20:47 GMT
… real-world treatment impact. Daiichi Sankyo has shared final long … president, US medical affairs, Daiichi Sankyo, added: “The final results … term benefit of Turalio. Daiichi Sankyo is proud to have … 3 Trial. News release. Daiichi Sankyo. July 9, 2025. Accessed …
Pexidartinib Shows Long-Term Safety and Efficacy in Symptomatic TGCT 09 Jul 2025 20:40 GMT
… Affairs at Daiichi Sankyo, added in the news release.1 “Daiichi Sankyo is proud … phase 3 trial. News release. Daiichi-Sankyo. July 9, 2025. Accessed July …
Bispecifics/BiTE Market Anticipates Impressive Growth Trajectory During the Forecast Period (2025-2034) Across 7MM Due to Their Expansion Beyond Oncology | DelveInsight 08 Jul 2025 22:30 GMT
… , Roche, Shanghai Henlius Biotech, AbbVie, Daiichi Sankyo, Nuvation Bio, PDC*line Pharma …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS